Citations

Showing 10 of 108081 citations.

Operative Efficiency of Thoracoabdominal Hepatectomy for Right-sided Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
Lawson, Damon Izaac, Phillips, Alisa L. , Fleming, Andrew, Drake, Justin A. , Murphy, Andrew James , Yakoub, Danny , Glazer, Evan S.

Mayo Clinic

Journal of the American College of Surgeons | April 17, 2023 | Volume: 236 | Issue: 5 | Pages: S64-S65

10.1097/01.xcs.0000932852.89502.f6 Get It

A Flipped Classroom Model To Enhance Simulation Education For Percutaneous Renal Surgery
Koo, Kevin , Liaw, Christine , Bearrick, Elizabeth , Ungerer, Garrett , Granberg, Candace F. , Potretzke, Aaron M. , Findlay, Bridget L. , Viers, Boyd R.

Mayo Clinic

Journal of the American College of Surgeons | April 17, 2023 | Volume: 236 | Issue: 5 | Pages: S140-S140

10.1097/01.xcs.0000933560.78123.e6 Get It

Continuous Suture vs Interrupted Suture Duct-to-mucosa Pancreatojejunostomy After Pancreatoduodenectomy: A Systematic Review and Meta-analysis of Comparative Studies
Thomas, Jonathan Christian, Deneve, Jeremiah L. , Dickson, Paxton V. , Fleming, Andrew, Drake, Justin A. , Glazer, Evan S. , Yakoub, Danny

Mayo Clinic

Journal of the American College of Surgeons | April 17, 2023 | Volume: 236 | Issue: 5 | Pages: S59-S59

10.1097/01.xcs.0000932792.21130.bf Get It

Ex Vivo Perfusion of Discarded Donor Liver Segments for Comparative Therapeutic Investigations
Mohamed, Mohamed I. , Lu, Kang , Katta, Lavanya, Song, ZuoRui, Brown, Thomas D. , Orlando, Christopher , Nakhleh, Raouf E. , Kirkland, James L. , Kang, Lu, Brown, Thomas, Tchkonia, Tamar , Nguyen, Justin Hung

Mayo Clinic

Journal of the American College of Surgeons | April 17, 2023 | Volume: 236 | Issue: 5 | Pages: S118-S119

10.1097/01.xcs.0000933336.90051.69 Get It

Is YouTube a Good Resource for Laparoscopic Adrenalectomy Education Content?
Orton, Taylor S., Eldredge, Richard S, Hangge, Patrick T., Wasif, Nabil , Stucky, Chee-Chee H, Eldredge, R Scott , Deshpande, Anagha , Stucky, Chee‐Chee , Cronin, Patricia A

Mayo Clinic

Journal of the American College of Surgeons | April 17, 2023 | Volume: 236 | Issue: 5 | Pages: S26-S26

10.1097/01.xcs.0000932468.42395.f5 Get It

Microsurgical Reconstruction in Patients With Oncologic Disease
Movtchan, Nellie V., Casey, William J., Rebecca, Alanna M. , Kruger, Erwin A., Teven, Chad M. , Kandi, Lyndsay A.

Mayo Clinic

Journal of the American College of Surgeons | April 17, 2023 | Volume: 236 | Issue: 5 | Pages: S93-S93

10.1097/01.xcs.0000933104.64942.3c Get It

A Novel ypTLM Staging System Based on LODDS for Gastric Cancer After Neoadjuvant Therapy: Multicenter and Large‐Sample Retrospective Study
Que, Si‐Jin, Zhong, Qing , Truty, Mark J. , Yan, Su , Ma, Yu‐Bin , Ding, Fanghui , Zheng, Chao‐Hui , Li, Ping , Wang, Jia‐Bin , Lü, Jun, Cao, Long‐Long, Lin, Ju‐Li , Zheng, Hua‐Long , Huang, Chang‐Ming , Chen, Qi‐Yue , Lin, Jian‐Xian , Lin, Mi , Tu, Ru‐Hong

Mayo Clinic

World Journal of Surgery | April 17, 2023 | Volume: 47 | Issue: 7 | Pages: 1762-1771

10.1007/s00268-023-06994-7 | PMID 37069317 Get It

AbstractBackgroundThe accuracy of the eighth AJCC ypTNM staging system on the prognosis of gastric cancer (GC) patients after neoadjuvant therapy (NAT) is controversial. This study aimed to develop and validate a novel staging system using the log odds of positive lymph nodes scheme (LODDS).MethodsA retrospective analysis of 606 GC patients who underwent radical gastrectomy after neoadjuvant therapy was conducted as the development cohort. (Fujian Medical University Affiliated Union Hospital (n = 183), Qinghai University Affiliated Hospital (n = 169), Mayo Clinic (n = 236), Lanzhou University First Hospital (n = 18)). The validation cohort came from the SEER database (n = 1701). A novel ypTLoddsS (ypTLM) staging system was established using the 3‐year overall survival. The predictive performance of two systems was compared. ResultsTwo‐step multivariate Cox regression analysis in both cohorts showed that ypTLM was an independent predictor of overall survival of GC patients after neoadjuvant therapy (HR: 1.57, 95% CI: 1.30–1.88, p < 0.001). In the development cohort, ypTLM had better discrimination ability than ypTNM (C‐index: 0.663 vs 0.633, p < 0.001), better prediction homogeneity (LR: 97.7 vs. 70.9), and better prediction accuracy (BIC: 3067.01 vs 3093.82; NRI: 0.36). In the validation cohort, ypTLM had a better prognostic predictive ability (C‐index: 0.614 vs 0.588, p < 0.001; LR: 11,909.05 vs. 11,975.75; BIC: 13,263.71 vs 13,328.24; NRI: 0.22). The time‐dependent ROC curve shows that the predictive performance of ypTLM is better than ypTNM, and the analysis of the decision curve shows that ypTLM achieved better net benefits. ConclusionA LODDS‐based ypTLM staging system based on multicenter data was established and validated. The predictive performance was superior to the eighth AJCC ypTNM staging system.
Escaping the Long Shadow Cast by Agranulocytosis
León, José de , Arrojo, Manuel , Verdoux, Hélène , Ruan, Can‐Jun , Schoretsanitis, Georgios , Rohde, Christopher , Cohen, Dan , Schulte, Peter F.J. , Kim, Se Hyun , Cotes, Robert O. , Leung, Jonathan G. , Otsuka, Yuji , Кирилочев, О.О. , Every‐Palmer, Susanna , Clark, Scott R. , Motuca, Mariano , Wilkowska, Alina , Yağcıoğlu, A. Elif Anıl , Lazáry, Judit , Sanz, Emílio J. , Cuevas, Carlos De las , de Leon, Jose , Arrojo-Romero, Manuel , Kirilochev, Oleg O , Baptista, Trino , Grover, Sandeep , Every-Palmer, Susanna , Clark, Scott , McGrane, Ian , Motuca, Mariano , Olmos, Ismael , Wilkowska, Alina , Sagud, Marina , Ignjatovic Ristic, Dragana , Lazary, Judit , Sanz, Emilio J , Leung, Jonathan G , Ruan, Can-Jun , Kim, Se Hyun , Rohde, Christopher , De Las Cuevas, Carlos , Schulte, Peter F J , Anıl Yağcıoğlu, A Elif , Cotes, Robert O , Otsuka, Yuji , Schoretsanitis, Georgios , McGrane, Ian R. , Ristić, Dragana Ignjatović

Mayo Clinic

Journal of Clinical Psychopharmacology | April 17, 2023 | Volume: 43 | Issue: 3 | Pages: 239-245

10.1097/jcp.0000000000001678 | PMID 37068034 Get It

Abstract Purpose/Background A recent article in this journal presented a US perspective regarding the modernization of clozapine prescription and proposed an escape from the long shadow cast by agranulocytosis. Methods Here, an international group of collaborators discusses a point of view complementary to the US view by focusing on worldwide outcomes of clozapine usage that may be uneven in terms of frequency of clozapine adverse drug reactions. Findings/Results Studies from the Scandinavian national registries (Finland and Denmark) did not find increased mortality in clozapine patients or any clear evidence of the alleged toxicity of clozapine. Data on clozapine-associated fatal outcomes were obtained from 2 recently published pharmacovigilance studies and from the UK pharmacovigilance database. A pharmacovigilance study focused on physician reports to assess worldwide lethality of drugs from 2010 to 2019 found 968 clozapine-associated fatal outcomes in the United Kingdom. Moreover, the United Kingdom accounted for 55% (968 of 1761) of worldwide and 90% (968 of 1073) of European fatal clozapine-associated outcomes. In a pharmacovigilance study from the UK database (from 2008 to 2017), clozapine was associated with 383 fatal outcomes/year including all reports from physicians and nonphysicians. From 2018 to 2021, UK clozapine-associated fatal outcomes increased to 440/year. Implications/Conclusions The interpretation of fatal outcomes in each country using pharmacovigilance databases is limited and only allows gross comparisons; even with those limitations, the UK data seem concerning. Pneumonia and myocarditis may be more important than agranulocytosis in explaining the uneven distribution of fatal outcomes in clozapine patients across countries.
Low‐grade adenosquamous carcinoma of the breast: a clinical, morphological and immunohistochemical analysis of 25 patients
Lewis, Gloria J., Fong, Nancy, Gjeorgjievski, Sandra Gjorgova , Li, Xiaoxian , Li, Zaibo , Wei, Shi, Sturgis, Charles D. , Wang, Chunjie , Komforti, Miglena K. , Downs, Erinn, Cui, Xiaoyan , Rowe, J. Jordi, Zhang, Gloria, Komforti, Miglena, Hoda, Raza S , Zhang, Gloria , Lewis, Gloria, Zhang, Huina , McIntire, Patrick J. , Hoda, Raza S. , Sciallis, Andrew P.

Mayo Clinic

Histopathology | April 17, 2023 | Volume: 83 | Issue: 2 | Pages: 252-263

10.1111/his.14917 | PMID 37067767 Get It

AimsDue to its rarity and non‐specific clinical and pathological features, low‐grade adenosquamous carcinoma (LGASC) of the breast continues to pose diagnostic challenges. Unlike other triple‐negative breast carcinomas, LGASC tends to have an indolent clinical behaviour. It is essential to recognise this lesion for accurate diagnosis and appropriate management.Methods and resultsTwenty‐five cases of LGASC were identified in our archives and collaborating institutes. Cases of LGASC with dominant coexisting other type carcinomas were excluded. We studied the clinical presentation, morphological features, patterns of the commonly used immunohistochemical stains and follow‐up. In our cohort, LGASC was commonly located at the outer aspect of the breast and associated with intraductal papilloma. The morphology of LGASC is characterised by infiltrating small glands and nests with variable squamous differentiation. We also found cuffing desmoplastic (fibrolamellar) stromal change in 75% of patients and peripheral lymphocytic aggregates in 87.5% of patients. P63 and smooth muscle myosin (SMM) were the most common myoepithelial markers used to assist in diagnosis. P63 often stained peripheral tumour cells surrounding invasive glands (circumferential staining in 80% of the cases), mimicking myoepithelial cells. It also stained the small nests with squamous differentiation. However, SMM was negative in 63% of the cases. The vast majority of our cases were triple‐negative; only a few had focal and weak expressions of ER and PR. One patient who did not have excision developed lymph node metastasis. Most patients underwent excision or mastectomy with negative margins as surgical treatment; there were no recurrences or metastases in these patients with clinical follow‐ups up to 108 months.ConclusionsLGASC has some unique, although not entirely specific, morphological features and immunohistochemical staining patterns. Fibrolamellar stromal change, peripheral lymphocytic aggregates and variable staining of p63 and SMM are valuable features to facilitate the diagnosis.
RAB27B Drives a Cancer Stem Cell Phenotype in NSCLC Cells Through Enhanced Extracellular Vesicle Secretion
Meneses, Kayleah M. , Pandya, Prita , Lindemann, Jennifer A. , Al-Qasrawi, Dania S. , Argo, Ryan A. , Weems, Celeste M. , Beetler, Danielle J. , Vijay, Geraldine V. , Yan, Irene K. , Wolfram, Joy , Justilien, Verline , Patel, Tushar , Justilien, Verline , Wolfram, Joy , Pandya, Prita , Patel, Tushar

Mayo Clinic

Cancer Research Communications | April 17, 2023 | Volume: 3 | Issue: 4 | Pages: 607-620

10.1158/2767-9764.crc-22-0425 | PMID 37077938 Get It

Cancer stem cells (CSC) within non–small cell lung carcinoma (NSCLC) tumors drive NSCLC progression, metastasis, relapse, and intrinsic chemoresistance. Understanding the mechanisms that support the malignant phenotypes of NSCLC CSCs may provide insights for improved NSCLC therapeutic interventions. Here, we report that expression of RAB27B, a small GTPase, is significantly upregulated in NSCLC CSCs when compared with bulk cancer cells (BCC). Short hairpin RNA–mediated knockdown of RAB27B leads to a loss of stem cell marker gene expression and reduced NSCLC spheroid growth, clonal expansion, transformed growth, invasion, and tumorigenicity. We find that NSCLC CSCs secrete significantly more extracellular vesicles (EV) than BCCs, and that this is RAB27B-dependent. Furthermore, CSC-derived EVs, but not BCC-derived EVs, induce spheroid growth, clonal expansion, and invasion in BCCs. Finally, RAB27B is required for CSC-derived EV-induced stemness in BCCs. Taken together, our results indicate that RAB27B is required for maintenance of a highly tumorigenic, cancer-initiating, invasive stem-like cell population in NSCLC and RAB27B is involved in propagating EV-mediated communication from NSCLC CSCs to BCCs. Our findings further suggest that inhibition of RAB27B-dependent EV secretion may be a potential therapeutic strategy for NSCLC. Significance: Expression of RAB27B in CSCs leads to elevated levels of EVs that mediate communication between CSCs and BCCs that maintains a stem-like phenotype in NSCLC cells.